WebDisclosure WebDisclosure
Basculer en Français
10456 Companies
219615 Keywords
148995 Articles
116127 Press releases
Headlines Articles Press releases Prolacta Bioscience Remove
  1. Home
  2. Companies
  3. Prolacta Bioscience
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/19/2026 at 08:10, 3 months 7 days ago

    Japan Approves Prolacta's Human Milk Fortifiers as Prescription Drug

    Neonatal Care Japan Approval Infant Nutrition Prolacta Human Milk-based
  • BRIEF

    published on 02/19/2026 at 08:10, 3 months 7 days ago

    Le Japon approuve les fortifiants de lait maternel de Prolacta comme médicament sur ordonnance

    Soins Néonatals Approbation Du Japon Nutrition Infantile Prolacta À Base De Lait Maternel
  • PRESS RELEASE

    published on 02/19/2026 at 08:05, 3 months 7 days ago

    A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

    Japan approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as Prescription Drug for Vulnerable Infants, supported by clinical evidence and regulatory milestones
    Japan Neonatal Care Prolacta Bioscience 100% Human Milk-Based Fortifiers Prescription Drug
    Logo of Prolacta Bioscience
Accesswire
  • Published on 05/26/2026 at 17:40, 1 hour 16 minutes ago

    New Horizon Aircraft Ltd. Announces Pricing of $25 Million Offering of Common Shares

  • Published on 05/26/2026 at 14:30, 4 hours 26 minutes ago

    Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources

  • Published on 05/26/2026 at 14:30, 4 hours 26 minutes ago

    Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments

  • Published on 05/26/2026 at 14:30, 4 hours 26 minutes ago

    In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides

  • Published on 05/26/2026 at 14:15, 4 hours 41 minutes ago

    Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy

View all ACCESSWIRE
EQS Group
  • Published on 05/26/2026 at 18:30, 26 minutes ago

    H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast

  • Published on 05/26/2026 at 17:45, 1 hour 11 minutes ago

    FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN

  • Published on 05/26/2026 at 17:30, 1 hour 26 minutes ago

    GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)

  • Published on 05/26/2026 at 17:30, 1 hour 26 minutes ago

    GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 26 05 2026

  • Published on 05/26/2026 at 16:30, 2 hours 25 minutes ago

    M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed

View all EQS
Les Echos
  • Published on 05/26/2026 at 18:39, 16 minutes ago

    Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026

  • Published on 05/26/2026 at 18:39, 16 minutes ago

    Reporting on share buyback transactions carried out on May 18, 2026

  • Published on 05/26/2026 at 17:45, 1 hour 11 minutes ago

    EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS

  • Published on 05/26/2026 at 17:45, 1 hour 11 minutes ago

    EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION

  • Published on 05/26/2026 at 17:40, 1 hour 16 minutes ago

    LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy